676 related articles for article (PubMed ID: 25609816)
1. Severe acute respiratory syndrome coronaviruses with mutations in the E protein are attenuated and promising vaccine candidates.
Regla-Nava JA; Nieto-Torres JL; Jimenez-Guardeño JM; Fernandez-Delgado R; Fett C; Castaño-Rodríguez C; Perlman S; Enjuanes L; DeDiego ML
J Virol; 2015 Apr; 89(7):3870-87. PubMed ID: 25609816
[TBL] [Abstract][Full Text] [Related]
2. Complete protection against severe acute respiratory syndrome coronavirus-mediated lethal respiratory disease in aged mice by immunization with a mouse-adapted virus lacking E protein.
Fett C; DeDiego ML; Regla-Nava JA; Enjuanes L; Perlman S
J Virol; 2013 Jun; 87(12):6551-9. PubMed ID: 23576515
[TBL] [Abstract][Full Text] [Related]
3. Immunization with an attenuated severe acute respiratory syndrome coronavirus deleted in E protein protects against lethal respiratory disease.
Netland J; DeDiego ML; Zhao J; Fett C; Álvarez E; Nieto-Torres JL; Enjuanes L; Perlman S
Virology; 2010 Mar; 399(1):120-128. PubMed ID: 20110095
[TBL] [Abstract][Full Text] [Related]
4. Severe acute respiratory syndrome coronavirus envelope protein regulates cell stress response and apoptosis.
DeDiego ML; Nieto-Torres JL; Jiménez-Guardeño JM; Regla-Nava JA; Alvarez E; Oliveros JC; Zhao J; Fett C; Perlman S; Enjuanes L
PLoS Pathog; 2011 Oct; 7(10):e1002315. PubMed ID: 22028656
[TBL] [Abstract][Full Text] [Related]
5. A live attenuated severe acute respiratory syndrome coronavirus is immunogenic and efficacious in golden Syrian hamsters.
Lamirande EW; DeDiego ML; Roberts A; Jackson JP; Alvarez E; Sheahan T; Shieh WJ; Zaki SR; Baric R; Enjuanes L; Subbarao K
J Virol; 2008 Aug; 82(15):7721-4. PubMed ID: 18463152
[TBL] [Abstract][Full Text] [Related]
6. Coronavirus virulence genes with main focus on SARS-CoV envelope gene.
DeDiego ML; Nieto-Torres JL; Jimenez-Guardeño JM; Regla-Nava JA; Castaño-Rodriguez C; Fernandez-Delgado R; Usera F; Enjuanes L
Virus Res; 2014 Dec; 194():124-37. PubMed ID: 25093995
[TBL] [Abstract][Full Text] [Related]
7. Severe acute respiratory syndrome-associated coronavirus vaccines formulated with delta inulin adjuvants provide enhanced protection while ameliorating lung eosinophilic immunopathology.
Honda-Okubo Y; Barnard D; Ong CH; Peng BH; Tseng CT; Petrovsky N
J Virol; 2015 Mar; 89(6):2995-3007. PubMed ID: 25520500
[TBL] [Abstract][Full Text] [Related]
8. Virus-specific memory CD8 T cells provide substantial protection from lethal severe acute respiratory syndrome coronavirus infection.
Channappanavar R; Fett C; Zhao J; Meyerholz DK; Perlman S
J Virol; 2014 Oct; 88(19):11034-44. PubMed ID: 25056892
[TBL] [Abstract][Full Text] [Related]
9. Identification of the Mechanisms Causing Reversion to Virulence in an Attenuated SARS-CoV for the Design of a Genetically Stable Vaccine.
Jimenez-Guardeño JM; Regla-Nava JA; Nieto-Torres JL; DeDiego ML; Castaño-Rodriguez C; Fernandez-Delgado R; Perlman S; Enjuanes L
PLoS Pathog; 2015 Oct; 11(10):e1005215. PubMed ID: 26513244
[TBL] [Abstract][Full Text] [Related]
10. Molecular Basis of Coronavirus Virulence and Vaccine Development.
Enjuanes L; Zuñiga S; Castaño-Rodriguez C; Gutierrez-Alvarez J; Canton J; Sola I
Adv Virus Res; 2016; 96():245-286. PubMed ID: 27712626
[TBL] [Abstract][Full Text] [Related]
11. Priming with SARS CoV S DNA and boosting with SARS CoV S epitopes specific for CD4+ and CD8+ T cells promote cellular immune responses.
Huang J; Cao Y; Du J; Bu X; Ma R; Wu C
Vaccine; 2007 Sep; 25(39-40):6981-91. PubMed ID: 17709158
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of NF-κB-mediated inflammation in severe acute respiratory syndrome coronavirus-infected mice increases survival.
DeDiego ML; Nieto-Torres JL; Regla-Nava JA; Jimenez-Guardeño JM; Fernandez-Delgado R; Fett C; Castaño-Rodriguez C; Perlman S; Enjuanes L
J Virol; 2014 Jan; 88(2):913-24. PubMed ID: 24198408
[TBL] [Abstract][Full Text] [Related]
13. Pathogenicity of severe acute respiratory coronavirus deletion mutants in hACE-2 transgenic mice.
Dediego ML; Pewe L; Alvarez E; Rejas MT; Perlman S; Enjuanes L
Virology; 2008 Jul; 376(2):379-89. PubMed ID: 18452964
[TBL] [Abstract][Full Text] [Related]
14. Severe acute respiratory syndrome vaccine development: experiences of vaccination against avian infectious bronchitis coronavirus.
Cavanagh D
Avian Pathol; 2003 Dec; 32(6):567-82. PubMed ID: 14676007
[TBL] [Abstract][Full Text] [Related]
15. Chimeric severe acute respiratory syndrome coronavirus (SARS-CoV) S glycoprotein and influenza matrix 1 efficiently form virus-like particles (VLPs) that protect mice against challenge with SARS-CoV.
Liu YV; Massare MJ; Barnard DL; Kort T; Nathan M; Wang L; Smith G
Vaccine; 2011 Sep; 29(38):6606-13. PubMed ID: 21762752
[TBL] [Abstract][Full Text] [Related]
16. Effects of Toll-like receptor stimulation on eosinophilic infiltration in lungs of BALB/c mice immunized with UV-inactivated severe acute respiratory syndrome-related coronavirus vaccine.
Iwata-Yoshikawa N; Uda A; Suzuki T; Tsunetsugu-Yokota Y; Sato Y; Morikawa S; Tashiro M; Sata T; Hasegawa H; Nagata N
J Virol; 2014 Aug; 88(15):8597-614. PubMed ID: 24850731
[TBL] [Abstract][Full Text] [Related]
17. Successful vaccination strategies that protect aged mice from lethal challenge from influenza virus and heterologous severe acute respiratory syndrome coronavirus.
Sheahan T; Whitmore A; Long K; Ferris M; Rockx B; Funkhouser W; Donaldson E; Gralinski L; Collier M; Heise M; Davis N; Johnston R; Baric RS
J Virol; 2011 Jan; 85(1):217-30. PubMed ID: 20980507
[TBL] [Abstract][Full Text] [Related]
18. The PDZ-binding motif of severe acute respiratory syndrome coronavirus envelope protein is a determinant of viral pathogenesis.
Jimenez-Guardeño JM; Nieto-Torres JL; DeDiego ML; Regla-Nava JA; Fernandez-Delgado R; Castaño-Rodriguez C; Enjuanes L
PLoS Pathog; 2014 Aug; 10(8):e1004320. PubMed ID: 25122212
[TBL] [Abstract][Full Text] [Related]
19. Prior immunization with severe acute respiratory syndrome (SARS)-associated coronavirus (SARS-CoV) nucleocapsid protein causes severe pneumonia in mice infected with SARS-CoV.
Yasui F; Kai C; Kitabatake M; Inoue S; Yoneda M; Yokochi S; Kase R; Sekiguchi S; Morita K; Hishima T; Suzuki H; Karamatsu K; Yasutomi Y; Shida H; Kidokoro M; Mizuno K; Matsushima K; Kohara M
J Immunol; 2008 Nov; 181(9):6337-48. PubMed ID: 18941225
[TBL] [Abstract][Full Text] [Related]
20. Induction of specific immune responses by severe acute respiratory syndrome coronavirus spike DNA vaccine with or without interleukin-2 immunization using different vaccination routes in mice.
Hu H; Lu X; Tao L; Bai B; Zhang Z; Chen Y; Zheng F; Chen J; Chen Z; Wang H
Clin Vaccine Immunol; 2007 Jul; 14(7):894-901. PubMed ID: 17494640
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
